Evaluating the cost-effectiveness of testing pregnant women for penicillin allergy.

ABSTRACT:

Introduction

True penicillin allergy is rare and is commonly incorrectly reported. In fact, less than five percent of patients who report a penicillin allergy will have a currently active clinically-significant IgE- or T-cell-mediated hypersensitivity when appropriately tested. Penicillin is the agent of choice for intrapartum antibiotic prophylaxis to reduce the risk of group B streptococcus early-onset disease in the newborn. Inaccurate penicillin allergy status may lead to inappropriate antibiotic use, as most alternative drugs are more expensive and broader spectrum than penicillin. Penicillin allergy testing has been found to be safe in pregnancy and cost-effective in other patient populations.

Objective

To evaluate the cost-effectiveness of penicillin allergy testing a

SUBMITTER: Thao V 

PROVIDER: S-EPMC9858404 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature